Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples